"Biomarkers, Tumor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS.
| Descriptor ID |
D014408
|
| MeSH Number(s) |
D23.101.140
|
| Concept/Terms |
Biomarkers, Tumor- Biomarkers, Tumor
- Tumor Biomarkers
- Markers, Biological Tumor
- Tumor Markers, Biological
- Markers, Tumor Metabolite
- Tumor Metabolite Markers
- Metabolite Markers, Tumor
- Marker, Tumor Metabolite
- Metabolite Marker, Tumor
- Tumor Metabolite Marker
- Tumor Markers, Biologic
- Biologic Tumor Markers
- Markers, Biologic Tumor
- Marker, Biologic Tumor
- Biologic Tumor Marker
- Tumor Marker, Biologic
- Biochemical Tumor Markers
- Markers, Biochemical Tumor
- Marker, Biochemical Tumor
- Biochemical Tumor Marker
- Tumor Marker, Biochemical
- Tumor Markers, Biochemical
- Carcinogen Markers
- Markers, Carcinogen
- Markers, Neoplasm Metabolite
- Neoplasm Metabolite Markers
- Marker, Neoplasm Metabolite
- Metabolite Marker, Neoplasm
- Neoplasm Metabolite Marker
- Metabolite Markers, Neoplasm
- Biological Tumor Markers
- Biological Tumor Marker
- Tumor Marker, Biological
- Marker, Biological Tumor
Markers, Tumor- Markers, Tumor
- Tumor Markers
- Biomarkers, Cancer
- Cancer Biomarkers
|
Below are MeSH descriptors whose meaning is more general than "Biomarkers, Tumor".
Below are MeSH descriptors whose meaning is more specific than "Biomarkers, Tumor".
This graph shows the total number of publications written about "Biomarkers, Tumor" by people in this website by year, and whether "Biomarkers, Tumor" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1997 | 2 | 0 | 2 |
| 1998 | 5 | 3 | 8 |
| 1999 | 6 | 2 | 8 |
| 2000 | 5 | 1 | 6 |
| 2001 | 7 | 2 | 9 |
| 2002 | 4 | 6 | 10 |
| 2003 | 10 | 13 | 23 |
| 2004 | 12 | 6 | 18 |
| 2005 | 16 | 15 | 31 |
| 2006 | 17 | 10 | 27 |
| 2007 | 18 | 11 | 29 |
| 2008 | 17 | 13 | 30 |
| 2009 | 20 | 20 | 40 |
| 2010 | 20 | 21 | 41 |
| 2011 | 14 | 26 | 40 |
| 2012 | 21 | 17 | 38 |
| 2013 | 27 | 22 | 49 |
| 2014 | 29 | 19 | 48 |
| 2015 | 37 | 23 | 60 |
| 2016 | 34 | 31 | 65 |
| 2017 | 41 | 24 | 65 |
| 2018 | 43 | 28 | 71 |
| 2019 | 33 | 39 | 72 |
| 2020 | 43 | 24 | 67 |
| 2021 | 42 | 29 | 71 |
| 2022 | 2 | 32 | 34 |
| 2023 | 3 | 13 | 16 |
| 2024 | 12 | 28 | 40 |
| 2025 | 33 | 31 | 64 |
| 2026 | 18 | 9 | 27 |
To return to the timeline,
click here.
Below are the most recent publications written about "Biomarkers, Tumor" by people in Profiles.
-
Methylation signatures distinguish non-small cell lung cancer subtypes and are associated with survival in smokers with lung squamous cell carcinoma. J Natl Cancer Inst. 2026 Jul 01; 118(7):1299-1312.
-
Glyoxalase 1 promotes glioma progression by modulating Sox2 transcriptional networks in glioma stem-like cells. Neuro Oncol. 2026 Jul 01; 28(7):1680-1693.
-
Biomarker study of pembrolizumab in patients with advanced rare cancers. Cell Rep Med. 2026 Jun 16; 7(6):102827.
-
Integrated proteogenomic and metabolomic profiling of acute myeloid leukemias to identify molecular subtypes and associated therapy targets. Nat Cancer. 2026 Jun; 7(6):993-1015.
-
Prognostic Value of Inflammatory Biomarkers as Continuous Variables in Metastatic Renal Cell Carcinoma: Linearity Assessment, Proportional Hazards Assumption Testing, and Time-Varying Effects. Int J Urol. 2026 Jun; 33(6):e70536.
-
Appendiceal Adenocarcinoma Cytoreduction Outcomes and Perioperative Serum Tumor Marker Levels. JAMA Netw Open. 2026 May 01; 9(5):e2610569.
-
Development of a multiplex assay for early detection of pancreatic cancer in high-risk groups. BMC Cancer. 2026 Apr 21; 26(1).
-
AGA Clinical Practice Update on Risk Stratification and Emerging Surveillance Strategies for Hepatocellular Carcinoma: Expert Review. Gastroenterology. 2026 06; 170(7):1606-1615.
-
Integrated Spatial Analysis Reveals the Molecular Landscape of Ovarian Precancerous Lesions. Cancer Res. 2026 Apr 02; 86(7):1739-1752.
-
Intracranial mesenchymal tumor, FET::CREB fusion-positive: An integrative analysis of 81 cases. Neuro Oncol. 2026 Apr 01; 28(4):939-951.